• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TANK通过激活AKT信号通路促进压力超负荷诱导的心脏肥大。

TANK Promotes Pressure Overload Induced Cardiac Hypertrophy Activating AKT Signaling Pathway.

作者信息

Pang Yanan, Ma Minglu, Wang Dong, Li Xun, Jiang Li

机构信息

Division of Cardiology, TongRen Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Cardiology, The First Affliated Hospital of Soochow University, Suzhou, China.

出版信息

Front Cardiovasc Med. 2021 Sep 3;8:687540. doi: 10.3389/fcvm.2021.687540. eCollection 2021.

DOI:10.3389/fcvm.2021.687540
PMID:34540911
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8446676/
Abstract

TANK (TRAF family member associated NF-κB activator) acts as a member of scaffold proteins participated in the development of multiple diseases. However, its function in process of cardiac hypertrophy is still unknown. In this study, we observed an increased expression of TANK in murine hypertrophic hearts after aortic banding, suggesting that TANK may be involved in the pathogenesis of cardiac hypertrophy. We generated cardiac-specific TANK knockout mice, and subsequently subjected to aortic banding for 4-8 weeks. TANK knockout mice showed attenuated cardiac hypertrophy and dysfunction compared to the control group. In contrast, cardiac-specific TANK transgenic mice showed opposite signs. Consistently, experiments revealed that TANK knockdown decreased the cell size and expression of hypertrophic markers. Mechanistically, AKT signaling was inhibited in TANK knockout mice, but activated in TANK transgenic mice after aortic banding. Blocking AKT signaling with a pharmacological AKT inhibitor alleviated the cardiac hypertrophy and dysfunction in TANK transgenic mice. Collectively, we identified TANK accelerates the progression of pathological cardiac hypertrophy and is a potential therapeutic target.

摘要

TANK(肿瘤坏死因子受体相关因子家族成员相关的核因子κB激活剂)作为支架蛋白家族的一员,参与多种疾病的发生发展。然而,其在心肌肥厚过程中的作用尚不清楚。在本研究中,我们观察到主动脉缩窄后小鼠肥厚心脏中TANK表达增加,提示TANK可能参与心肌肥厚的发病机制。我们构建了心脏特异性TANK基因敲除小鼠,随后进行4至8周的主动脉缩窄。与对照组相比,TANK基因敲除小鼠的心肌肥厚和功能障碍有所减轻。相反,心脏特异性TANK转基因小鼠表现出相反的体征。一致地,实验表明TANK基因敲低可减小细胞大小并降低肥厚标志物的表达。机制上,TANK基因敲除小鼠的AKT信号通路受到抑制,而主动脉缩窄后的TANK转基因小鼠中该信号通路被激活。用药物性AKT抑制剂阻断AKT信号通路可减轻TANK转基因小鼠的心肌肥厚和功能障碍。总体而言,我们确定TANK可加速病理性心肌肥厚的进展,是一个潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/8446676/4acbcef62a61/fcvm-08-687540-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/8446676/d0320f12dea6/fcvm-08-687540-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/8446676/63d68c16f30c/fcvm-08-687540-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/8446676/00c71676c882/fcvm-08-687540-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/8446676/3d2ecf34e703/fcvm-08-687540-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/8446676/3419d377d0f3/fcvm-08-687540-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/8446676/aaeb9d6aae23/fcvm-08-687540-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/8446676/4f670c70ce7c/fcvm-08-687540-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/8446676/4acbcef62a61/fcvm-08-687540-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/8446676/d0320f12dea6/fcvm-08-687540-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/8446676/63d68c16f30c/fcvm-08-687540-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/8446676/00c71676c882/fcvm-08-687540-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/8446676/3d2ecf34e703/fcvm-08-687540-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/8446676/3419d377d0f3/fcvm-08-687540-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/8446676/aaeb9d6aae23/fcvm-08-687540-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/8446676/4f670c70ce7c/fcvm-08-687540-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/079b/8446676/4acbcef62a61/fcvm-08-687540-g0008.jpg

相似文献

1
TANK Promotes Pressure Overload Induced Cardiac Hypertrophy Activating AKT Signaling Pathway.TANK通过激活AKT信号通路促进压力超负荷诱导的心脏肥大。
Front Cardiovasc Med. 2021 Sep 3;8:687540. doi: 10.3389/fcvm.2021.687540. eCollection 2021.
2
Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy.肿瘤坏死因子受体相关因子3是病理性心脏肥大的正向调节因子。
Hypertension. 2015 Aug;66(2):356-67. doi: 10.1161/HYPERTENSIONAHA.115.05469. Epub 2015 Jun 1.
3
Leukocyte immunoglobulin-like receptor B4 protects against cardiac hypertrophy via SHP-2-dependent inhibition of the NF-κB pathway.白细胞免疫球蛋白样受体 B4 通过 SHP-2 依赖性抑制 NF-κB 通路来保护心脏免受肥大。
J Mol Med (Berl). 2020 May;98(5):691-705. doi: 10.1007/s00109-020-01896-w. Epub 2020 Apr 12.
4
Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy.PHLDA3 在病理性心肌肥厚调控中的新作用
J Am Heart Assoc. 2019 Aug 20;8(16):e011830. doi: 10.1161/JAHA.118.011830.
5
Growth Arrest-Specific 6 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy.生长停滞特异性蛋白6加剧压力超负荷诱导的心脏肥大。
Hypertension. 2016 Jan;67(1):118-29. doi: 10.1161/HYPERTENSIONAHA.115.06254. Epub 2015 Nov 16.
6
C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction.C-C基序趋化因子受体9加剧压力超负荷诱导的心肌肥大和功能障碍。
J Am Heart Assoc. 2016 May 4;5(5):e003342. doi: 10.1161/JAHA.116.003342.
7
ZNF307 (Zinc Finger Protein 307) Acts as a Negative Regulator of Pressure Overload-Induced Cardiac Hypertrophy.锌指蛋白307(ZNF307)作为压力超负荷诱导的心脏肥大的负调节因子。
Hypertension. 2017 Apr;69(4):615-624. doi: 10.1161/HYPERTENSIONAHA.116.08500. Epub 2017 Feb 21.
8
ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK - AKT Signaling.ADAM23 在心肌细胞中通过靶向 FAK - AKT 信号抑制心肌肥厚。
J Am Heart Assoc. 2018 Sep 18;7(18):e008604. doi: 10.1161/JAHA.118.008604.
9
Regulator of G-Protein Signaling 10 Negatively Regulates Cardiac Remodeling by Blocking Mitogen-Activated Protein Kinase-Extracellular Signal-Regulated Protein Kinase 1/2 Signaling.G蛋白信号调节因子10通过阻断丝裂原活化蛋白激酶-细胞外信号调节蛋白激酶1/2信号通路负向调节心脏重塑。
Hypertension. 2016 Jan;67(1):86-98. doi: 10.1161/HYPERTENSIONAHA.115.05957. Epub 2015 Nov 16.
10
Regulator of G Protein Signaling 6 Facilities Cardiac Hypertrophy by Activating Apoptosis Signal-Regulating Kinase 1-P38/c-JUN N-Terminal Kinase 1/2 Signaling.G 蛋白信号调节因子 6 通过激活凋亡信号调节激酶 1-P38/c-JUN N-末端激酶 1/2 信号促进心肌肥厚。
J Am Heart Assoc. 2018 Oct 2;7(19):e009179. doi: 10.1161/JAHA.118.009179.

引用本文的文献

1
Trim38 attenuates pressure overload‑induced cardiac hypertrophy by suppressing the TAK1/JNK/P38 signaling pathway.Trim38通过抑制TAK1/JNK/P38信号通路减轻压力超负荷诱导的心脏肥大。
Int J Mol Med. 2025 Jun;55(6). doi: 10.3892/ijmm.2025.5539. Epub 2025 May 2.
2
Heat shock protein HSPA13 promotes hepatocellular carcinoma progression by stabilizing TANK.热休克蛋白HSPA13通过稳定TANK促进肝细胞癌进展。
Cell Death Discov. 2023 Dec 8;9(1):443. doi: 10.1038/s41420-023-01735-0.

本文引用的文献

1
Regulation of 8-Hydroxydaidzein in IRF3-Mediated Gene Expression in LPS-Stimulated Murine Macrophages.8-羟基大豆苷元在 LPS 刺激的小鼠巨噬细胞中 IRF3 介导的基因表达中的调控作用。
Biomolecules. 2020 Feb 4;10(2):238. doi: 10.3390/biom10020238.
2
New Insights Into the Role of mTOR Signaling in the Cardiovascular System.mTOR 信号在心血管系统中的作用的新见解。
Circ Res. 2018 Feb 2;122(3):489-505. doi: 10.1161/CIRCRESAHA.117.311147.
3
Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.《2018年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2018 Mar 20;137(12):e67-e492. doi: 10.1161/CIR.0000000000000558. Epub 2018 Jan 31.
4
Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage.塞内卡谷病毒通过靶向衔接蛋白MAVS、TRIF和TANK进行切割来抑制宿主I型干扰素的产生。
J Virol. 2017 Jul 27;91(16). doi: 10.1128/JVI.00823-17. Print 2017 Aug 15.
5
Encephalomyocarditis virus 3C protease attenuates type I interferon production through disrupting the TANK-TBK1-IKKε-IRF3 complex.脑心肌炎病毒3C蛋白酶通过破坏TANK-TBK1-IKKε-IRF3复合物来减弱I型干扰素的产生。
Biochem J. 2017 Jun 9;474(12):2051-2065. doi: 10.1042/BCJ20161037.
6
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy.长链非编码RNA Chaer定义了心脏肥大中的一个表观遗传检查点。
Nat Med. 2016 Oct;22(10):1131-1139. doi: 10.1038/nm.4179. Epub 2016 Sep 12.
7
Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy.抑制 IKKɛ 是病理性心肌肥厚的一个必要的负调控因子。
Nat Commun. 2016 Jun 1;7:11432. doi: 10.1038/ncomms11432.
8
The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling.泛素 E3 连接酶 TRAF6 通过 TAK1 依赖性信号转导加重病理性心肌肥厚。
Nat Commun. 2016 Jun 1;7:11267. doi: 10.1038/ncomms11267.
9
Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression.I类组蛋白去乙酰化酶的抑制通过TSC2依赖的mTOR抑制减轻心脏肥大。
Sci Signal. 2016 Apr 5;9(422):ra34. doi: 10.1126/scisignal.aad5736.
10
Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.微小RNA-99a的过表达减轻心脏肥大。
PLoS One. 2016 Feb 25;11(2):e0148480. doi: 10.1371/journal.pone.0148480. eCollection 2016.